← Open Payments lookup

MIKAILA LUGO-SCHLEGEL: Open Payments

NPI 1346959129 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,102 in 175 payments from 15 companies in 2025. Trend: 2023 $2,661 · 2024 $3,136 · 2025 $3,102

Food & beverage: $2,934Education: $168
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.37$1,077
Otsuka America Pharmaceutical, Inc.41$530
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$391
Alkermes, Inc.20$301
Supernus Pharmaceuticals, Inc.15$186
Neurocrine BioSciences, Inc.13$180
Janssen Pharmaceuticals, Inc5$87
E.R. Squibb & Sons, L.L.C.5$87
Axsome Therapeutics, Inc.4$77
ABBVIE INC.3$53

Products named: UZEDY, REXULTI, CAPLYTA, AUSTEDO XR, LYBALVI, Qelbree, INGREZZA, ABILIFY ASIMTUFII.

Industry payments across PA — which companies pay providers there.